[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550
Sort by:

Birch Pollen Allergy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BIRCH POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Birch Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Birch Pollen Allergy Pipeline candidates across various development ...

August 2018 30 pages

Blepharitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF BLEPHARITIS PIPELINE REPORT INCLUDES Panorama of Blepharitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 50 pages

Bone Fracture R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BONE FRACTURE PIPELINE REPORT INCLUDES Panorama of Bone Fracture pipeline markets including statistics on therapeutic drugs and companies involved Bone Fracture Pipeline candidates across various development ...

August 2018 80 pages

Bone Metastasis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BONE METASTASIS PIPELINE REPORT INCLUDES Panorama of Bone Metastasis pipeline markets including statistics on therapeutic drugs and companies involved Bone Metastasis Pipeline candidates across various development ...

August 2018 80 pages

Botulism R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF BOTULISM PIPELINE REPORT INCLUDES Panorama of Botulism pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Brain Edema R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BRAIN EDEMA PIPELINE REPORT INCLUDES Panorama of Brain Edema pipeline markets including statistics on therapeutic drugs and companies involved Brain Edema Pipeline candidates across various development ...

August 2018 30 pages

Brain Hemorrhage R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BRAIN HEMORRHAGE PIPELINE REPORT INCLUDES Panorama of Brain Hemorrhage pipeline markets including statistics on therapeutic drugs and companies involved Brain Hemorrhage Pipeline candidates across various development ...

August 2018 40 pages

Brain Ischemia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BRAIN ISCHEMIA PIPELINE REPORT INCLUDES Panorama of Brain Ischemia pipeline markets including statistics on therapeutic drugs and companies involved Brain Ischemia Pipeline candidates across various development ...

August 2018 40 pages

Bronchiectasis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF BRONCHIECTASIS PIPELINE REPORT INCLUDES Panorama of Bronchiectasis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

Bronchitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF BRONCHITIS PIPELINE REPORT INCLUDES Panorama of Bronchitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 50 pages

Bronchopulmonary Dysplasia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BRONCHOPULMONARY DYSPLASIA PIPELINE REPORT INCLUDES Panorama of Bronchopulmonary Dysplasia pipeline markets including statistics on therapeutic drugs and companies involved Bronchopulmonary Dysplasia Pipeline candidates across various development ...

August 2018 50 pages

Bullous Pemphigoid R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BULLOUS PEMPHIGOID PIPELINE REPORT INCLUDES Panorama of Bullous Pemphigoid pipeline markets including statistics on therapeutic drugs and companies involved Bullous Pemphigoid Pipeline candidates across various development ...

August 2018 50 pages

Burkholderia Infections R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BURKHOLDERIA INFECTIONS PIPELINE REPORT INCLUDES Panorama of Burkholderia Infections pipeline markets including statistics on therapeutic drugs and companies involved Burkholderia Infections Pipeline candidates across various development ...

August 2018 60 pages

Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF BURKITT LYMPHOMA PIPELINE REPORT INCLUDES Panorama of Burkitt Lymphoma pipeline markets including statistics on therapeutic drugs and companies involved Burkitt Lymphoma Pipeline candidates across various development ...

August 2018 100 pages

Burns R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF BURNS PIPELINE REPORT INCLUDES Panorama of Burns pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 80 pages

Cachexia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF CACHEXIA PIPELINE REPORT INCLUDES Panorama of Cachexia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Canavan Disease R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CANAVAN DISEASE PIPELINE REPORT INCLUDES Panorama of Canavan Disease pipeline markets including statistics on therapeutic drugs and companies involved Canavan Disease Pipeline candidates across various development ...

August 2018 20 pages

Cancer Anorexia Cachexia Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF CANCER ANOREXIA CACHEXIA SYNDROME PIPELINE REPORT INCLUDES Panorama of Cancer Anorexia Cachexia Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Cancer Anorexia Cachexia Syndrome Pipeline candidates across ...

August 2018 90 pages

Cancer Pain R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CANCER PAIN PIPELINE REPORT INCLUDES Panorama of Cancer Pain pipeline markets including statistics on therapeutic drugs and companies involved Cancer Pain Pipeline candidates across various development ...

August 2018 100 pages

Candidiasis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF CANDIDIASIS PIPELINE REPORT INCLUDES Panorama of Candidiasis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 140 pages

Cat Allergy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CAT ALLERGY PIPELINE REPORT INCLUDES Panorama of Cat Allergy pipeline markets including statistics on therapeutic drugs and companies involved Cat Allergy Pipeline candidates across various development ...

August 2018 20 pages

Cataract R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF CATARACT PIPELINE REPORT INCLUDES Panorama of Cataract pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Cedar Pollen Allergy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CEDAR POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Cedar Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Cedar Pollen Allergy Pipeline candidates across various development ...

August 2018 30 pages

Celiac Disease R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CELIAC DISEASE PIPELINE REPORT INCLUDES Panorama of Celiac Disease pipeline markets including statistics on therapeutic drugs and companies involved Celiac Disease Pipeline candidates across various development ...

August 2018 70 pages

Cerebral Malaria R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CEREBRAL MALARIA PIPELINE REPORT INCLUDES Panorama of Cerebral Malaria pipeline markets including statistics on therapeutic drugs and companies involved Cerebral Malaria Pipeline candidates across various development ...

August 2018 30 pages

Cerebral Palsy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CEREBRAL PALSY PIPELINE REPORT INCLUDES Panorama of Cerebral Palsy pipeline markets including statistics on therapeutic drugs and companies involved Cerebral Palsy Pipeline candidates across various development ...

August 2018 30 pages

Cervical Intraepithelial Neoplasia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CERVICAL INTRAEPITHELIAL NEOPLASIA PIPELINE REPORT INCLUDES Panorama of Cervical Intraepithelial Neoplasia pipeline markets including statistics on therapeutic drugs and companies involved Cervical Intraepithelial Neoplasia Pipeline candidates across various development ...

August 2018 80 pages

Chagas Disease (American Trypanosomiasis) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) PIPELINE REPORT INCLUDES Panorama of Chagas Disease (American Trypanosomiasis) pipeline markets including statistics on therapeutic drugs and companies involved Chagas Disease (American Trypanosomiasis) Pipeline candidates across ...

August 2018 70 pages

Charcot Marie Tooth Disease (Type I A) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHARCOT MARIE TOOTH DISEASE (TYPE I A) PIPELINE REPORT INCLUDES Panorama of Charcot Marie Tooth Disease (Type I A) pipeline markets including statistics on therapeutic drugs and companies involved Charcot Marie Tooth Disease (Type I A) Pipeline candidates ...

August 2018 40 pages

Charcot Marie Tooth Disease R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF CHARCOT MARIE TOOTH DISEASE PIPELINE REPORT INCLUDES Panorama of Charcot Marie Tooth Disease pipeline markets including statistics on therapeutic drugs and companies involved Charcot Marie Tooth Disease Pipeline candidates across ...

August 2018 50 pages

Chemotherapy Induced Anemia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHEMOTHERAPY INDUCED ANEMIA PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Anemia pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Anemia Pipeline candidates across various development ...

August 2018 40 pages

Chemotherapy Induced Nausea and Vomiting R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... . SCOPE OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Nausea and Vomiting pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Nausea and Vomiting Pipeline ...

August 2018 70 pages

Chemotherapy Induced Neutropenia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHEMOTHERAPY INDUCED NEUTROPENIA PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Neutropenia pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Neutropenia Pipeline candidates across various development ...

August 2018 90 pages

Chemotherapy Induced Peripheral Neuropathy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Chemotherapy Induced Peripheral Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Chemotherapy Induced Peripheral Neuropathy Pipeline candidates across ...

August 2018 100 pages

Chikungunya Fever R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHIKUNGUNYA FEVER PIPELINE REPORT INCLUDES Panorama of Chikungunya Fever pipeline markets including statistics on therapeutic drugs and companies involved Chikungunya Fever Pipeline candidates across various development ...

August 2018 80 pages

Chlamydia Infections R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHLAMYDIA INFECTIONS PIPELINE REPORT INCLUDES Panorama of Chlamydia Infections pipeline markets including statistics on therapeutic drugs and companies involved Chlamydia Infections Pipeline candidates across various development ...

August 2018 60 pages

Cholera R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF CHOLERA PIPELINE REPORT INCLUDES Panorama of Cholera pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Chondrosarcoma R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF CHONDROSARCOMA PIPELINE REPORT INCLUDES Panorama of Chondrosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 220 pages

Choroidal Neovascularization R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHOROIDAL NEOVASCULARIZATION PIPELINE REPORT INCLUDES Panorama of Choroidal Neovascularization pipeline markets including statistics on therapeutic drugs and companies involved Choroidal Neovascularization Pipeline candidates across various development ...

August 2018 40 pages

Chronic Cough R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHRONIC COUGH PIPELINE REPORT INCLUDES Panorama of Chronic Cough pipeline markets including statistics on therapeutic drugs and companies involved Chronic Cough Pipeline candidates across various development ...

August 2018 50 pages

Chronic Heart Failure R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHRONIC HEART FAILURE PIPELINE REPORT INCLUDES Panorama of Chronic Heart Failure pipeline markets including statistics on therapeutic drugs and companies involved Chronic Heart Failure Pipeline candidates across various development ...

August 2018 120 pages

Chronic Inflammatory Demyelinating Polyneuropathy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... use format. SCOPE OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY PIPELINE REPORT INCLUDES Panorama of Chronic Inflammatory Demyelinating Polyneuropathy pipeline markets including statistics on therapeutic drugs and companies involved Chronic Inflammatory Demyelinating Polyneuropathy Pipeline candidates ...

August 2018 40 pages

Chronic Kidney Disease (Chronic Renal Failure) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... . SCOPE OF CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) PIPELINE REPORT INCLUDES Panorama of Chronic Kidney Disease (Chronic Renal Failure) pipeline markets including statistics on therapeutic drugs and companies involved Chronic Kidney Disease (Chronic Renal Failure) Pipeline ...

August 2018 180 pages

Chronic Urticaria R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CHRONIC URTICARIA PIPELINE REPORT INCLUDES Panorama of Chronic Urticaria pipeline markets including statistics on therapeutic drugs and companies involved Chronic Urticaria Pipeline candidates across various development ...

August 2018 50 pages

Clostridium difficile Infection R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CLOSTRIDIUM DIFFICILE INFECTION PIPELINE REPORT INCLUDES Panorama of Clostridium difficile Infection pipeline markets including statistics on therapeutic drugs and companies involved Clostridium difficile Infection Pipeline candidates across various development ...

August 2018 160 pages

Cluster Headache Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF CLUSTER HEADACHE SYNDROME PIPELINE REPORT INCLUDES Panorama of Cluster Headache Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Cluster Headache Syndrome Pipeline candidates across various development ...

August 2018 40 pages

Coccidioidomycosis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF COCCIDIOIDOMYCOSIS PIPELINE REPORT INCLUDES Panorama of Coccidioidomycosis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Colitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF COLITIS PIPELINE REPORT INCLUDES Panorama of Colitis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 70 pages

Community Acquired Methicillin Resistant Staphylococcus aureus Infections R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... of Community Acquired Methicillin Resistant Staphylococcus aureusInfections pipeline products. The Community Acquired Methicillin Resistant Staphylococcus aureusInfections pipeline guide presents complete overview of drugs currently being developed for Community Acquired Methicillin Resistant Staphylococcus ...

August 2018 40 pages

Community Acquired Pneumonia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF COMMUNITY ACQUIRED PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Community Acquired Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Community Acquired Pneumonia Pipeline candidates across various development ...

August 2018 90 pages

Filters

Search

Categories

370
94
242
550
1,143
110,057
94

Publishers

179
1
100
32
25
102
94
2,211
109
23
40
8,299
68
562
988
34
29,954
248
501
3,036
1
1
2
3
1
16
257
537
361
106
1
1,357
2,180
60
1,696
8
8,921
1,697
4
3,714
983
19
1
321
4,852
2,748
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
270
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
33
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
350
1
4
6
1
3
9
1
3
5
1
1
1
90
2
3
4
1
77
15
980
1
3
1
17
227
128
16
4
412
3
74
2
6
5
10
1
3
118
33
336
196
47
474
7
45
1
22
13
138
2
4

Regions

58
48
35
31
30
29
29
26
26
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
36
57
41
54
60
101
26
30
55
3
34
2
2
1,179
115
172
26
33
94
14
49
53
28
18
62
25
23
39
23
43
24
14
51
28
38
132
48
65
67
204
52
17
56
42
31
48
47
37
36
19
62
150
34
31
30
17
17
16
14
136
57
49
30
15
457
1,819
71
1,614
921
765
184
2,008
99,858

Price

Date

Pages

Offers

93
23
905
1
2,735
269
1
1